The use of pool cryoglobulin factor 8 concentrate in the management of haemophilia

J R O'Brien. Proc R Soc Med. 1967 Mar.

. 1967 Mar;60(3):243-4.

doi: 10.1177/003591576706000321.

No abstract available

Similar articles

Preparation and testing of antihemophilic globulin (Factor 8) sources for transfusion therapy in hemophilia. Description of a new sterile concentrate process for blood banks.
Pool JG. Pool JG. Scand J Clin Lab Invest. 1965;17:Suppl 84:70-7. Scand J Clin Lab Invest. 1965. PMID: 5862567 No abstract available.
Antihaemophilic cryoprecipitate from fresh plasma and its use in haemophilia.
Brüster H, Glassner K, Riech PC. Brüster H, et al. Ger Med Mon. 1968 Mar;13(3):129-33. Ger Med Mon. 1968. PMID: 5656869 No abstract available.
[Hemophilia: the blood bank's concern?].
Smit Sibinga CT. Smit Sibinga CT. Ned Tijdschr Geneeskd. 1978 Sep 16;122(37):1359-62. Ned Tijdschr Geneeskd. 1978. PMID: 692762 Dutch. No abstract available.
Previously untreated patients and recombinant factor VIII concentrate studies.
Pasi KJ. Pasi KJ. Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S29-32. Blood Coagul Fibrinolysis. 1997. PMID: 9351534 Review.
Viral safety of plasma-derived factor VIII and IX concentrates.
Ludlam CA. Ludlam CA. Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S19-23. Blood Coagul Fibrinolysis. 1997. PMID: 9351532 Review.